Authors

• A.F. Burnette
• Benjamin Emmanuel (ORCID: https://orcid.org/0000-0003-1769-9826)
• Njira Lucia Lugogo (ORCID: https://orcid.org/0000-0002-0235-7105)
• Kaharu Sumino (ORCID: https://orcid.org/0000-0002-6214-2966)
• Sameer K. Mathur (ORCID: https://orcid.org/0000-0001-7656-0256)
• Praveen Akuthota (ORCID: https://orcid.org/0000-0001-6655-7520)
• Andrew Lindsley (ORCID: https://orcid.org/0000-0003-2670-704X)
• Cinzia Marchese (ORCID: https://orcid.org/0000-0002-9280-8917)
• Christopher S. Ambrose (ORCID: https://orcid.org/0000-0003-4175-7336)
• Jean‐Pierre Llanos (ORCID: https://orcid.org/0000-0002-7785-6881)

Institutions

• Amgen (United States) (US)
• University of Wisconsin–Madison (US)
• Howard University (US)
• Washington University in St. Louis (US)
• University of Michigan (US)
• University of California System (US)
• University of California San Diego (US)
• AstraZeneca (France) (FR)
• AstraZeneca (Sweden) (SE)

Publication Details

Journal

Advances in Therapy

Published

2025-05-19

DOI

https://doi.org/10.1007/s12325-025-03231-6

Citations

11

Primary Topic

Asthma and respiratory diseases

Type

article

Field-Weighted Citation Impact

12.81

Funders

• Amgen
• AstraZeneca